profit from every CHF 100 of sales.
CHF 0CHF 100
SKAN Group
CHF 68.60-1.15% today
+41.7% in 1 year
1-year low CHF 40.401-year high CHF 76.30
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay CHF 94.78 for every CHF 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What SKAN Group sold, what it kept, and what it did with the cash.
Sales went from CHF 277 million in 2022 to CHF 333 million in 2025, with CHF 16.3 million of profit last year.
SalesProfit
SKAN Group handed back 49% of the cash it generated last year.
CHF 9M
Free cash flow 2025CHF 18M
Bought back its own shares–
Paid as dividendsCHF 9M
Cash vs. debtCHF 94M vs. CHF 131M
SKAN Group vs. similar companies
SKAN Group grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from CHF 100 of sales | Sales growth a year | Price per CHF 1 of profit |
|---|---|---|---|
| SKAN Group | 94.8× · Very expensive | ||
 Intuitive Surgical | 53.8× · Expensive | ||
 EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Becton, Dickinson and | 35.4× · Expensive | ||
 Medline | 44.8× · Expensive |
AI analysis
An AI analyst reads SKAN Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 277 | 320 | 361 | 333 | |
| 200 | 241 | 266 | 257 | |
| 29 | 38 | 44 | 25 | |
| 36 | 46 | 60 | 36 | |
| 19 | 26 | 39 | 16 | |
| 0.84 | 1.17 | 1.73 | 0.72 | |
| 72.4% | 75.2% | 73.6% | 77.0% | |
| 10.6% | 11.8% | 12.3% | 7.6% | |
| 6.9% | 8.2% | 10.7% | 4.9% |
Balance sheet
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 388 | 373 | 384 | 481 |
| Cash | 111 | 85 | 54 | 94 |
| Total debt | 17 | 6 | 11 | 131 |
| Total liabilities | 223 | 197 | 182 | 353 |
| 157 | 169 | 196 | 114 | |
| 22 | 22 | 22 | 22 | |
| 12.5% | 16.0% | 19.4% | 7.7% | |
| 12.1% | 15.5% | 19.8% | 14.2% |
Cash flow
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 61 | 9 | 47 | 64 | |
| 29 | 35 | 54 | 46 | |
| 33 | -27 | -7 | 18 | |
| Dividends paid | 5 | 6 | 8 | 9 |
| 1 | – | – | – | |
| – | – | – | – |
Valuation
- 94.8×
- –
- –
- 9.5×
- 4.6×
- 84.6×
- 44.5×
- 1.2%
- 1.1%
- 0.6%
Profitability
- 77.0%
- 7.6%
- 4.9%
- –
- 7.7%
- 13.9%
- –
- –
- –
- –
Growth
- +6.4%
- −5.0%
- –
- –
- +0.0%
Financial health
- 1.1×
- 1.15
- –
- 22.8×
- 1.31
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 42%of 963
Bottom 42%of 894
Bottom 10%of 632
Bottom 34%of 908
Bottom 48%of 991
0.6%of the share price, paid each year
On $1,000 invested$6a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
55.3% of its profit
Room to growStretchedMore than it earns: 49.3%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
50No pass
Benjamin Graham
30No pass
Philip Fisher
37No pass
Peter Lynch
21No pass
Joel Greenblatt
4No pass
Charlie Munger
36No pass
Terry Smith
40No pass
Questions about SKAN Group
Is SKAN Group a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the SKAN Group AI analysis
What does SKAN Group do?
SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It is in Medical Instruments & Supplies, based in Allschwil, Switzerland, with 1,557 employees.
Does SKAN Group pay a dividend?
Yes. At today's price the dividend is 0.6% a year, about 55% of its yearly profit. In 2025 it paid out CHF 8.99 million in dividends.
Is SKAN Group stock halal?
Yes. SKAN Group passes our halal screen: its business is permitted and its debt is 9% of its market value, under the 30% limit. How we check
How has SKAN Group stock done over the past year?
Up 41.7% over the past twelve months, to CHF 68.60. It traded between CHF 40.40 and CHF 76.30 and is 10.1% below its high.
Who are SKAN Group's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with SKAN Group's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.